Leukaemia (chronic lymphocytic, relapsed) - rituximab: appeal announcement
The Institute received 2 appeals from UK Chronic Lymphocytic Leukaemia (CLL) Forum and a joint appeal from Royal College of Pathologists and the British Society for Haematology.
The appeal hearing took place at NICE, MidCity Place 71 High Holborn, London WC1V 6NA on Tuesday 25 May 2010 at 11am.
The Institute awaits the decision of the Appeal Panel.
This page was last updated: 16 August 2010